University Briefs

Hewlett-Packard Co. founder David Packard has just given $2 billion to the trust he and his late wife established in 1964 and young researchers will be among the beneficiaries. The David and Lucile Packard Foundation plans to dole out 20 $500,000 awards this year and has already asked 50 top research universities to nominate two junior professors each. But only natural scientists and engineers need apply; research projects in medicine, space activity, and high-energy physics are ineligible. Th

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hewlett-Packard Co. founder David Packard has just given $2 billion to the trust he and his late wife established in 1964 and young researchers will be among the beneficiaries. The David and Lucile Packard Foundation plans to dole out 20 $500,000 awards this year and has already asked 50 top research universities to nominate two junior professors each. But only natural scientists and engineers need apply; research projects in medicine, space activity, and high-energy physics are ineligible. The program, which will add 20 scientists each year, will eventually pump $10 million annually into science research. Its goal: to encourage young professors to remain in research and teaching.

Could university researchers become an endangered species by 1996? That’s the sobering prediction of a recent report by NSF’s Division of Policy Research and Analysis. Numbers of American 22- year-olds (and thus numbers of potential science majors) are steadily decreasing and will bottom ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies